Announcements Trials
Browse Landscape

Phase

Phase 3 6Phase NA 3Phase 4 2

Status

Completed 5Recruiting 1

Sponsor Class

INDUSTRY 6

Study Type

Interventional 6

Sponsor

Cancer Type

Classical hematology 6Lymphoid 2

Conditions

Anemia 64Neoplasms 38Venous Thromboembolism 29Leukemia 21Anemia, Refractory, with Excess of Blasts 20Myelodysplastic Syndromes 19Lymphoma 14Thrombocytopenia 13Multiple Myeloma 12Leukemia, Myelomonocytic, Chronic 12Venous Thrombosis 11Pulmonary Embolism 11Febrile Neutropenia 11Breast Neoplasms 10Myeloproliferative Disorders 9Lymphoma, Non-Hodgkin 9Leukemia, Lymphocytic, Chronic, B-Cell 9Neoplasms, Plasma Cell 8Lymphoma, Follicular 8Leukemia, Myeloid, Acute 8Primary Myelofibrosis 6Neutropenia 6Hodgkin Disease 6Hemophilia A 6Lung Neoplasms 5Anemia, Refractory 5Waldenstrom Macroglobulinemia 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Precancerous Conditions 4Lymphoproliferative Disorders 4

Interventions

emicizumab 4Factor VIII 2recombinant FVIIa 1anti-inhibitor coagulant complex 1BIVV001 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 3 × Hemophilia A × Classical hematology × Clear all
NCT06716814 2026-04-20

LIBERTY

Swedish Orphan Biovitrum

Phase 3 Recruiting
104 enrolled
Classical hematologyLymphoid

Blood Coagulation Disorders, Hemophilia A, Lymphoma, Follicular, Coagulation Protein Disorders

NCT03020160 2023-01-11

HAVEN 4

Hoffmann-La Roche

Phase 3 Completed
48 enrolled 44 charts 1 FDA
Classical hematology

Hemophilia A

NCT02847637 2022-11-16

HAVEN 3

Hoffmann-La Roche

Phase 3 Completed
152 enrolled 46 charts 1 FDA
Classical hematology

Hemophilia A

NCT02622321 2021-06-24

HAVEN 1

Hoffmann-La Roche

Phase 3 Completed
113 enrolled 45 charts 1 FDA
Classical hematology

Hemophilia A

NCT02795767 2021-06-02

HAVEN 2

Hoffmann-La Roche

Phase 3 Completed
88 enrolled 65 charts 1 FDA
Classical hematology

Hemophilia A

NCT00037544 2008-04-22

Study Evaluating ReFacto AF in Severe Hemophilia A

Wyeth is now a wholly owned subsidiary of Pfizer

Phase 3 Completed
Classical hematologyLymphoid

Hemophilia A, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡